Shuangdeng Group Co., Ltd. has disclosed a forthcoming change in its board’s independent oversight. Dr. Wang Jin submitted his resignation as Independent Non-Executive Director (INED) on 20 Oct 2026, citing increased external commitments. In accordance with PRC Company Law and the company’s Articles of Association, he will remain in post—and continue serving on the Audit Committee as well as chairing both the Remuneration and Nomination Committees—until shareholders approve a successor.
The Board has nominated Dr. Wang Jiajun, aged 44, to fill the vacant INED seat. Shareholders will vote on the appointment at an extraordinary general meeting (EGM) on 10 Nov 2026. If approved, Dr. Wang Jiajun will:
• Join the Audit Committee • Assume chairmanship of the Remuneration Committee • Assume chairmanship of the Nomination Committee
The proposed service agreement grants Dr. Wang Jiajun an annual fixed allowance of RMB0.15 million, aligned with prevailing market practice and his expected responsibilities.
Dr. Wang Jiajun holds a PhD in Chemical Engineering and Technology (Harbin Institute of Technology, 2008), completed post-doctoral research at the University of Western Ontario, and currently heads the Department of Electrochemistry at Harbin Institute of Technology. He reports no shareholdings in Shuangdeng, no related-party ties, and satisfies all independence criteria under Hong Kong Listing Rules 3.13(1)-(8).
A circular containing full details of the nomination and the EGM notice will be dispatched to shareholders in due course.
As of the announcement date, Shuangdeng’s Board comprises nine directors: three executives (including Chairman and CEO Dr. Yang Rui), three non-executives, and three independent non-executives.
Comments